Arthrolysis Surgery in India and UAE | Complete Patient Guide

• Patients with documented arthrofibrosis of the knee, elbow, shoulder, hip, or ankle causing a clinically significant loss of range of motion (typically >10° extension deficit or <90° flexion in the knee; functional arc <100° in the elbow) that has failed a structured, supervised physiotherapy program of at least 3–6 months duration

• Individuals with post-traumatic joint stiffness following fractures (distal femur, tibial plateau, radial head, distal humerus), ligamentous reconstructions (ACL, PCL, UCL), or total joint arthroplasty

• Patients with cyclops lesions or arthrofibrosis confirmed on MRI (high-signal fibrotic nodule anterior to PCL in ACL-reconstructed knees) or CT arthrography demonstrating capsular thickening >4 mm

• Candidates who have been assessed with validated outcome instruments: Oxford Knee Score, WOMAC, Mayo Elbow Performance Index, or Constant-Murley Score for shoulder, to establish a pre-operative baseline for outcome measurement

• Patients with a minimum interval of 3–6 months from the index injury or prior surgery (to allow the acute inflammatory phase to fully resolve before surgical release)

• Required pre-operative diagnostics: plain weight-bearing radiographs (AP, lateral, patellofemoral views), MRI of the affected joint with dedicated sequences for soft-tissue characterization, inflammatory markers (CRP, ESR, WBC) to exclude septic arthritis, coagulation profile (PT/INR, aPTT), complete blood count, metabolic panel, and ECG for patients over 40

• Patients with active intra-articular infection or septic arthritis (must be definitively excluded by synovial fluid analysis and culture before any surgical intervention)

• Relative contraindications: severe osteoporosis (DEXA T-score < −2.5) where capsular release risks iatrogenic fracture; uncontrolled inflammatory arthropathy (active rheumatoid arthritis or psoriatic arthritis with elevated disease activity score DAS28 > 3.2, requiring pre-operative rheumatologic optimization); complex regional pain syndrome (CRPS) Type I or II, which requires a multidisciplinary pain management plan before proceeding; patients with insufficient soft-tissue envelope or vascular compromise

• Absolute contraindications: active joint sepsis, uncontrolled systemic coagulopathy, advanced malignancy involving the periarticular structures

ARTHROSCOPIC ARTHROLYSIS (Minimally Invasive — First-Line Advanced Approach) Arthroscopic arthrolysis is the preferred technique at high-volume orthopedic centers in India and the UAE and represents the current gold standard for most cases of knee, shoulder, and elbow arthrofibrosis. Using 4 mm or 2.7 mm arthroscopes with high-definition 1080p or 4K imaging towers, the surgeon accesses the joint through 2–4 portal incisions (each <1 cm), employs a motorized full-radius resector shaver and a radiofrequency ablation (RFA) probe to systematically excise fibrotic tissue and contracted capsular tissue under direct visualization. In the knee, this includes anterior interval release (to free the infrapatellar fat pad from the patellar tendon and tibial plateau), medial and lateral gutters debridement, posterior capsular release using a 70° arthroscope, and excision of cyclops lesions. In the elbow, anterior and posterior capsulectomy with removal of coronoid, olecranon, and radial head osteophytes using an arthroscopic burr is performed sequentially. Robotic-assisted or navigation-guided arthroscopy is available at select JCI-accredited centers for cases involving complex deformity or prior implants, providing real-time kinematic feedback to optimize the degree of release.

OPEN ARTHROLYSIS (Selected Complex Cases) Open arthrolysis is indicated for cases with severe multi-plane contracture, failed prior arthroscopic release, or when concomitant procedures are required (e.g., quadricepsplasty, V-Y lengthening of the extensor mechanism, or hardware removal). A medial or lateral parapatellar approach (knee) or a Kocher approach (elbow) provides wider exposure. The surgeon performs a systematic release of all quadrants of the capsule, excises hypertrophic scar tissue, and addresses bony blocks to motion. Intraoperative fluoroscopy confirms the adequacy of release. Open arthrolysis carries a higher wound complication rate but may achieve greater initial range of motion in severely contracted joints.

DISTENSION ARTHROGRAPHY (Hydrodilatation) — Non-Surgical Option For adhesive capsulitis of the shoulder (frozen shoulder), image-guided hydrodilatation under fluoroscopy or ultrasound guidance involves injection of a mixture of normal saline (20–40 mL), corticosteroid (e.g., triamcinolone acetonide 40 mg), and local anesthetic into the glenohumeral joint to distend and rupture the contracted capsule. This is a day-case procedure performed before considering surgical arthroscopic capsulotomy, and is effective in Stage II adhesive capsulitis.

CONTINUOUS PASSIVE MOTION (CPM) AND MANIPULATION UNDER ANESTHESIA (MUA) MUA is a lower-risk adjunct used primarily in post-arthroplasty stiffness within the first 12 weeks of surgery, where the scar tissue has not yet fully matured. A structured, controlled force is applied under general or spinal anesthesia to break adhesions, followed by immediate CPM application. It is not suitable for cases with established mature fibrosis, osteoporosis, or implant concerns.

POST-OPERATIVE REHABILITATION PROTOCOL (CRITICAL TO OUTCOME) All surgical approaches are followed by a structured rehabilitation program: immediate CPM in the first 24–72 hours (0–90° range, progressing 5–10° daily), regional anesthesia nerve block (femoral or adductor canal block for knee; infraclavicular or axillary block for elbow/shoulder) maintained via catheter for 48–72 hours for pain-free early mobilization, followed by a 6–12 week supervised physiotherapy program with progressive stretching, quadriceps strengthening, and proprioceptive training. Dynamic splinting (Dynasplint or JAS static progressive splint) is prescribed for home use between sessions.

STEP 1 — REMOTE PRE-OPERATIVE ASSESSMENT (2–4 weeks before travel) The patient submits MRI reports, plain radiographs, operative records from prior surgeries, and a validated outcome score (Oxford Knee Score / Mayo Elbow Performance Index) to the GAF Healthcare medical coordination team. A board-certified orthopedic surgeon at the partner hospital reviews the imaging and prepares a pre-operative plan, including identification of the specific fibrotic compartments to be addressed. Blood tests (CBC, CRP, ESR, coagulation profile, metabolic panel) are either performed locally or upon arrival. The GAF team arranges an e-Medical visa for India (typically approved within 1–5 business days) or confirms UAE entry requirements.

STEP 2 — ARRIVAL AND FINAL WORKUP (Day 1–2) The patient arrives at the destination city and is received by a dedicated GAF case coordinator. On Day 1, a clinical consultation with the operating surgeon is conducted, during which the pre-operative MRI is re-reviewed and an examination under no anesthesia documents the precise arc of motion deficit. An anesthesia assessment is completed, and the surgical plan (arthroscopic vs. open, targeted compartments, nerve block strategy) is finalized. Pre-operative fasting begins the evening before surgery.

STEP 3 — SURGICAL DAY (Day 2–3) The procedure is performed under spinal anesthesia with sedation, or general anesthesia, depending on patient preference and surgeon recommendation. An ultrasound-guided nerve block catheter is placed prior to the procedure for post-operative analgesia. Arthroscopic arthrolysis of the knee typically takes 60–90 minutes; elbow arthrolysis 75–120 minutes. Intraoperative range of motion is confirmed under anesthesia before wound closure. The patient is transferred to the recovery room and CPM is commenced within 2–4 hours of surgery.

STEP 4 — IMMEDIATE POST-OPERATIVE PHASE (Day 3–5, In-Hospital) The nerve block catheter provides near-complete pain control for 48–72 hours, enabling aggressive early physiotherapy. A physiotherapist visits twice daily for active-assisted and active range-of-motion exercises. The surgical team confirms the achieved arc of motion on Day 2 post-op. Thromboprophylaxis with low-molecular-weight heparin (e.g., enoxaparin 40 mg subcutaneous daily) or rivaroxaban is initiated per protocol. Wound inspection and dressing change are performed before discharge.

STEP 5 — OUTPATIENT REHABILITATION PHASE (Week 1–3, In-Country) The patient is discharged to hotel or serviced apartment accommodation arranged by GAF Healthcare, with daily or twice-daily physiotherapy sessions at the hospital's outpatient rehabilitation department. Dynamic splinting (JAS or Dynasplint) is fitted and the patient is trained in its use for home sessions. The GAF coordinator arranges transport to all sessions. At the 2-week milestone, the surgeon performs a clinical review; if the arc of motion is tracking as planned (e.g., 0–100° in the knee or functional elbow arc 30–120°), fit-to-fly planning begins.

STEP 6 — FIT-TO-FLY CLEARANCE AND DEPARTURE (Week 3–6) Fit-to-fly status is granted when the surgical wound is fully healed, the patient demonstrates safe independent ambulation, the arc of motion is stable, and deep vein thrombosis risk is assessed as low (or bridging anticoagulation plan is confirmed with the home physician). For knee arthrolysis, this is typically 3–5 weeks post-surgery; for elbow or shoulder, 3–4 weeks. The GAF team provides a detailed discharge summary, post-operative rehabilitation protocol, and imaging reports formatted for the home country's treating physician.

STEP 7 — HOME COUNTRY FOLLOW-UP (Week 6–12) Continued physiotherapy using the prescribed protocol, dynamic splinting, and 6-week and 12-week teleconsultation reviews with the operating surgeon via the GAF Healthcare virtual follow-up program. Outcome is re-measured using the pre-operative baseline score.